Top Clinical Trials companies in Netherlands by Revenue
Netherlands
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 43.95 M
|
Dec. 31, 2023 | USD 39.01 | -3.56% |
|
Netherlands |
|
| 2 |
USD 15.84 M
|
Dec. 31, 2023 | USD 13.23 | -4.06% |
|
Netherlands |
|
| 3 |
USD 12.76 M
|
Dec. 31, 2023 | USD 23.67 | -3.70% |
|
Netherlands |
|
| 4 |
USD 7.19 M
|
Dec. 31, 2023 | USD 2.26 | -0.44% |
|
Netherlands |
|
| 5 |
USD 6.77 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
| 6 |
USD 0.00
|
Dec. 31, 2023 | USD 16.00 | -2.50% |
|
Netherlands |
Frequently Asked Questions
-
Which Clinical Trials company in Netherlands has the highest Revenue ?
The Clinical Trials company in Netherlands with the highest Revenue is Merus N.V. (NasdaqGM: MRUS) at USD 43.95 M.
-
Which Clinical Trials company in Netherlands has the lowest Revenue ?
The Clinical Trials company in Netherlands with the lowest Revenue is Pharvaris N.V. (NasdaqGS: PHVS) at USD 0.00.
-
What are the top 10 Clinical Trials companies in Netherlands by Revenue ?
The top 10 Clinical Trials companies in Netherlands by Revenue are Merus N.V., uniQure N.V., NewAmsterdam Pharma Company N.V., ProQR Therapeutics N.V., LAVA Therapeutics N.V. and Pharvaris N.V..
-
What are the bottom 10 Clinical Trials companies in Netherlands by Revenue ?
The bottom 10 Clinical Trials companies in Netherlands by Revenue are Pharvaris N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., NewAmsterdam Pharma Company N.V., uniQure N.V. and Merus N.V..